Cytotoxic and anti-angiogenic properties of minor 3,4-seco-cycloartanes from Gardenia sootepensis exudate

Chemical and Pharmaceutical Bulletin

Volumn 60, Issue 12, 2012, Pages 1538-1543

  Pudhom, Khanitha ^a   Nuanyai, Thanesuan ^a   Matsubara, Kiminori ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

3,4 seco cycloartane; Anti angiogenic; Cytotoxic; Gardenia sootepensis

Indexed keywords

3,4 SECO CYCLOARTANE TRITERPENE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; SOOTEPENDIAL; SOOTEPENOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BUD; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; GARDENIA; GARDENIA SOOTPENSIS; HUMAN; HUMAN CELL; MALE; MEDICINAL PLANT; NONHUMAN; RAT; SPECTROSCOPY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AORTA; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GARDENIA; HEP G2 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; PLANT EXUDATES; PLANT SHOOTS; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; TRITERPENES;

EID: 84871183972     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.c12-00699     Document Type: Article

References (22)

1. Folkman J., Shing Y., J. Biol. Chem., 267, 10931-10934 (1992).
2. Folkman J., Nat. Med., 1, 27-31 (1995).
3. Carmeliet P., Jain R. K., Nature (London), 407, 249-257 (2000).
4. Jain S. P., Int. J. Crude Drug Res., 27, 29-32 (1989).
5. Mbela T. K. M., Shabani M., Dieyi S., Cimanga K., Moswa L., Fitoterapia, 63, 179-181 (1992).
6. Woo W. S., Lee E. B., Shin K. H., Kang S. S., Chi H. J., Korean J. Pharmacogn., 12, 153-170 (1981).
7. Kirtikar K. R., Basu B. D., "Indian Medicinal Plants," 2nd ed., Vol. II, International Book Distributors, Dehradun, 1987, pp. 2128-2130.
8. Grougnet R., Magiatis P., Mitaku S., Loizou S., Moutsatsou P., Terzis A., Cabalion P., Tillequin F., Michel S., J. Nat. Prod., 69, 1711-1714 (2006).
9. Kunert O., Sreekanth G., Babu G. S., Rao B. V., Radhakishan M., Kumar B. R., Saf R., Rao A. V., Schühly W., Chem. Biodivers., 6, 1185-1192 (2009).
10. Nuanyai T., Sappapan R., Teerawatananond T., Muangsin N., Pudhom K., J. Nat. Prod., 72, 1161-1164 (2009).
11. Nuanyai T., Chokpaiboon S., Vilaivan T., Pudhom K., J. Nat. Prod., 73, 51-54 (2010).
12. Nuanyai T., Sappapan R., Vilaivan T., Pudhom K., Chem. Pharm. Bull., 59, 385-387 (2011).
13. Silva G. L., Gil R. R., Cui B., Chai H., Santisuk K., Srisook E., Reutrakul V., Tuchinda P., Sophasan S., Sujarit S., Upatham S., Lynn S. M., Farthing J. E., Yang S.-L., Lewis J. A., O'Neill M. J., Farnsworth N. R., Cordell G. A., Pezzuto J. M., Kinghorn A. D., Tetrahedron, 53, 529-538 (1997).
14. Reutrakul V., Krachangchaeng C., Tuchinda P., Pohmakotr M., Jaipetch T., Yoosook C., Kasisit J., Sophasan S., Sujarit K., Santisuk T., Tetrahedron, 60, 1517-1523 (2004).
15. Mori M., Sadahira Y., Kawasaki S., Hayashi T., Notohara K., Awai M., Acta Pathol. Jpn., 38, 1503-1512 (1988).
16. Kawasaki S., Mori M., Awai M., Acta Pathol. Jpn., 39, 712-718 (1989).
17. Kruger E. A., Duray P. H., Tsokos M. G., Venzon D. J., Libutti S. K., Dixon S. C., Rudek M. A., Pluda J., Allegra C., Figg W. D., Biochem. Biophys. Res. Commun., 268, 183-191 (2000).
18. Zogakis T. G., Costouros N. G., Kruger E. A., Forbes S., He M., Qian M., Feldman A. L., Figg W. D., Alexander H. R., Liu E. T., Kohn E. C., Libutti S. K., Biotechniques, 33, 664-666, 668, 670 (2002).
19. Ferrara N., Curr. Top. Microbiol. Immunol., 237, 1-30 (1999).
20. Shinkaruk S., Bayle M., Laïn G., Déléris G., Curr. Med. Chem. Anticancer Agents, 3, 95-117 (2003).
21. Kayashima T., Mori M., Yoshida H., Mizushina Y., Matsubara K., Cancer Lett., 278, 34-40 (2009).
22. Ganesan P., Matsubara K., Ohkubo T., Tanaka Y., Noda K., Sugawara T., Hirata T., Phytomedicine, 17, 1140-1144 (2010).